159 related articles for article (PubMed ID: 35232668)
1.
Broski SM; Johnson DR; Packard AT; Hunt CH
PET Clin; 2022 Apr; 17(2):249-263. PubMed ID: 35232668
[TBL] [Abstract][Full Text] [Related]
2. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: A systematic review.
Bertagna F; Nicolai P; Maroldi R; Mattavelli D; Bertoli M; Giubbini R; Lombardi D; Treglia G
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):295-302. PubMed ID: 26488055
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment quantitative
Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Utility of
Nakajima R; Patel SG; Katabi N; Flukes S; Mauguen A; Ganly I; Schöder H
AJR Am J Roentgenol; 2021 May; 216(5):1344-1356. PubMed ID: 33826358
[No Abstract] [Full Text] [Related]
6. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET Imaging of Salivary Gland Tumors.
Larson CR; Wiggins RH
Semin Ultrasound CT MR; 2019 Oct; 40(5):391-399. PubMed ID: 31635766
[TBL] [Abstract][Full Text] [Related]
8. Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET/CT.
Alabed YZ; Rakheja R; Laufer J
Clin Nucl Med; 2014 Jun; 39(6):549-50. PubMed ID: 24152625
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in the staging of cancer of the major salivary gland neoplasms.
Friedman ER; Saindane AM
Neuroimaging Clin N Am; 2013 Feb; 23(1):107-22. PubMed ID: 23199664
[TBL] [Abstract][Full Text] [Related]
10. [(18)F-fluorodeoxy glucose positron emission tomography/computed tomography manifestation and clinical characteristics of primary salivary gland-type lung cancer].
Ding CY; Li YY; Sun J; Guo Z; Li TR
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):288-293. PubMed ID: 31014054
[No Abstract] [Full Text] [Related]
11. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
12. Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Danstrup CS; Lyhne NM; Kovacsne A; Fisker R; Zacho HD
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):357-364. PubMed ID: 35939059
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in sublingual and submandibular salivary gland tumors.
Ma S; Liu Y
Mol Clin Oncol; 2020 Oct; 13(4):27. PubMed ID: 32765874
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Park MJ; Oh JS; Roh JL; Kim JS; Lee JH; Nam SY; Kim SY
Clin Nucl Med; 2017 Mar; 42(3):e149-e156. PubMed ID: 28072618
[TBL] [Abstract][Full Text] [Related]
15. Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
Westergaard-Nielsen M; Rohde M; Godballe C; Eriksen JG; Larsen SR; Gerke O; Nguyen N; Nielsen MK; Nielsen AL; Thomassen A; Asmussen JT; Diaz A; Høilund-Carlsen PF; Bjørndal K
Ann Nucl Med; 2019 Aug; 33(8):554-563. PubMed ID: 31102059
[TBL] [Abstract][Full Text] [Related]
16. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck.
Nakamura S; Okochi K; Murata Y; Shibuya H; Kurabayashi T
Nucl Med Commun; 2009 Jul; 30(7):498-503. PubMed ID: 19434008
[TBL] [Abstract][Full Text] [Related]
18. The impact of FDG-PET in the management of patients with salivary gland malignancy.
Otsuka H; Graham MM; Kogame M; Nishitani H
Ann Nucl Med; 2005 Dec; 19(8):691-4. PubMed ID: 16444995
[TBL] [Abstract][Full Text] [Related]
19. Detection of distant metastasis and prognostic prediction of recurrent salivary gland carcinomas using
Lee SH; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Dis; 2018 Sep; 24(6):940-947. PubMed ID: 29688610
[TBL] [Abstract][Full Text] [Related]
20. Re: 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Sabour S
Clin Nucl Med; 2017 Dec; 42(12):990. PubMed ID: 28737578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
